Heptazine Based Photo‐Programmable Azobenzene‐Amino Acid Nanotubes for Augmented Drug Delivery and Chemo‐Photodynamic Therapy in Glioma
Small · 2026-04 · 22 (22)
DOI: 10.1002/smll.202508544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 18.02.2026. Verfasst von Nidhi Aggarwal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Supramolecular Nanotherapeutics Laboratory, Chemical Biology Unit, Knowledge City, Institute of Nano Science and Technology, Mohali, Punjab…. Hauptthemen laut MEDLINE: Glioma, Azo Compounds, Photochemotherapy, Amino Acids. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Har-Gobind Khorana Young Innovative Biotechnologist, CEFIPRA CSRP, Indo-French Project for the Promotion of Advanced Research.
Abstract (Originalsprache)
Heptazine or tri‐ s ‐triazine, is one of the oldest known nitrogen‐containing heterocycles that kindled a new arena in biomedical research in the recent past due to their rich fascinating properties. Here, we report design and development of self‐assembled nano biomaterials consisting of heptazine‐derived π‐conjugated azobenzene for photo‐activated glioma therapy. The model anti‐cancer drug, Docetaxel is co‐assembled with heptazine‐derived π‐conjugated A zobenzene and Fmoc‐ I soleucine‐OH to form stable T ubular nanostructures (Dtx@AI‐Ts) . Due to the presence of photoisomerizable azobenzene moiety, AI‐Ts exhibit a light‐induced transformation to nanotubes of lesser dimensions upon 405 nm light irradiation, thereby improving drug release and enhancing their applicability as nano‐drug delivery systems. This structural adaptability, coupled with the material's ability to induce reactive oxygen species (ROS) upon light activation, helps to achieve higher therapeutic efficacy against glioma. In vitro therapeutic efficacy investigated in terms of cell viability (MTT assay) and oxidative stress generation demonstrates an enhanced therapeutic outcome with Dtx@AI‐Ts in C6 glioma cells. Further, in the C6 syngeneic glioma rat model, a prompted tumor depletion (∼90%) is observed post 21‐days of therapy, along with good compatibility toward healthy body organs. Thus, this work establishes the potential of smart self‐assembled drug loaded photo‐responsive nanomaterials toward enabling advanced glioma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain and Supramolecular Nanotherapeutics Laboratory, Chemical Biology Unit, Knowledge City, Institute of Nano Science and Technology, Mohali, Punjab, INDIA.
- Advanced Functional Nanomaterials, Knowledge City, Institute of Nano Science and Technology (INST), Mohali, Punjab, INDIA.
- Department of Chemical Sciences, Knowledge City, Indian Institute of Science Education and Research (IISER) Mohali, Mohali, Punjab, INDIA.
ORCID-Profile: Jiban Jyoti Panda
Förderung
- Har-Gobind Khorana Young Innovative Biotechnologist
- CEFIPRA CSRP
- Indo-French Project for the Promotion of Advanced Research
- DBT
- SERB-Power
- CSIR-EMR
- UGC- New Delhi
- CSIR- New Delhi
Zitieren
APA
Aggarwal, N., Kumar, P., Kharra, P., Dhingra, K., Saini, N., Choudhury, S., Kumar, A., Panda, H. S., Venkataramani, S., Kailasam, K., & Panda, J. J. (2026). Heptazine Based Photo‐Programmable Azobenzene‐Amino Acid Nanotubes for Augmented Drug Delivery and Chemo‐Photodynamic Therapy in Glioma. Small, 22(22). https://doi.org/10.1002/smll.202508544
Vancouver
Aggarwal N, Kumar P, Kharra P, Dhingra K, Saini N, Choudhury S, et al. Heptazine Based Photo‐Programmable Azobenzene‐Amino Acid Nanotubes for Augmented Drug Delivery and Chemo‐Photodynamic Therapy in Glioma. Small. 2026;22(22). doi:10.1002/smll.202508544
BibTeX
@article{Aggarwal2026,
author = {Aggarwal, Nidhi and Kumar, Pravesh and Kharra, Pankaj and Dhingra, Kirti and Saini, Neha and Choudhury, Samraggi and Kumar, Amit and Panda, Himanshu Sekhar and Venkataramani, Sugumar and Kailasam, Kamalakannan and Panda, Jiban Jyoti},
title = {Heptazine Based Photo‐Programmable Azobenzene‐Amino Acid Nanotubes for Augmented Drug Delivery and Chemo‐Photodynamic Therapy in Glioma},
journal = {Small},
year = {2026},
volume = {22},
number = {22},
doi = {10.1002/smll.202508544}
}
EUVIMED